Normal lung and heart function references for healthy US veterans who served in Southwest Asia
Official title: Lung and Heart Function Across Decades of Life in Healthy Population
Run by University of California, San Francisco · NCT07641413 · Data updated 2026-11-12
This study tests whether healthy veterans aged 24–68 who did not have exposure to airborne hazards have normal lung and heart function values that can serve as reference standards.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 24 Years to 68 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | University of California, San Francisco Academic / other |
| Locations | 1 site (San Francisco, California) |
| Status | Recruiting |
| Started | August 1, 2024 |
| Main results expected | December 31, 2030 |
| Study ends | December 31, 2030 |
| Registry record updated | September 14, 2026 |
| Trial ID | NCT07641413 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are veterans aged 24–68, deployed between 1990 and 2021, with no respiratory symptoms or exposure to airborne hazards.
✕Probably not a fit
Individuals with significant comorbidities, active smoking within the past year, pregnancy, or uncontrolled cardiovascular risk factors may not benefit from the reference data.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study will recruit 200 age- and gender-matched healthy veterans with no history of exposure to airborne hazards. Participants will undergo comprehensive evaluations aligned with the PDCEN Core Clinical Evaluation, including questionnaires, pulmonary function testing, oscillometry, CPET with maximum effort, echo, chest CT, and biomarker analysis. The goal is to establish baseline reference values for lung and heart function in this specific population, while also capturing childhood health and fitness data. Data will be collected to compare against veterans with exposure-related conditions and to inform future assessments of cardiopulmonary health in this group.
Why it matters
Potential benefit: If successful, the reference values could improve interpretation of lung and heart tests for veterans and help identify abnormal findings earlier.
How similar studies have gone: Prior studies have established healthy reference values in general populations, but this study focuses on a veteran cohort with Southwest Asia deployment history, making it a targeted but relatively novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria:
* Age 24-68
* U.S. Veteran deployed between 1990 to 2021
* No respiratory complaints (defined as modified Medical Research Council score = 0)
* No use of respiratory medications
Exclusion Criteria:
* Non-English speaking
* Pregnancy
* BMI\>35 Kg/m2
* Tobacco smoking within prior year
* Lifetime tobacco smoking of \>5 pack-years
* Current inhaled cannabis use (any modality) \>2x weekly
* Prior inhaled cannabis uses exceeding 2x weekly within the prior year
* Illicit drug use (other than cannabis)
* No prior or current major organ disease, including but not limited to:
* Neuromuscular weakness
* History of malignancy (other than non-melanoma skin cancer)-- HIV/AIDS
* Autoimmune disease
* Solid-organ or hematopoietic stem cell transplant
* Cardiovascular disease (other than mild HTN; \< 140/90; controlled on 2 or less medications)
* Poorly-controlled HTN (SBP\>140 or DBP\>90 or use of more than 2 anti-hypertensive medications)
* Any history of congestive heart failure (CHF, either HFpEF or HFrEF)
* Any history of arrythmia (including atrial fibrillation)
Where it's running
-
University of California San Francisco
San Francisco, California, United States Recruiting
Study contacts
- Principal investigator: Mehrdad Arjomandi, MD — University of California, San Francisco
- Study coordinator: Mehrdad Arjomandi, MD
- Email: mehrdad.arjomandi@ucsf.edu
- Phone: 415-221-4810
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pulmonary and cardiovascular rehabilitation program for chronic respiratory and heart conditions
This study tests a rehabilitation program that combines exercise for people with chronic lung and heart conditions to see if it helps them feel better and improve their daily activities.
-
How exposure to heavy metals, nanoparticles, and emerging contaminants relates to allergic skin and systemic metal reactions
This project will test whether adults with allergic contact dermatitis or systemic metal allergies have different levels of heavy metals, nanoparticles, and related blood and urine markers compared with healthy adults.
-
Assessing diaphragm function in patients with respiratory diseases
This study is testing how well the diaphragm works in people with respiratory diseases to see if it affects their breathing difficulties and overall health.
-
Research on lung cancer screening behaviors and outcomes in high-risk individuals in Taiwan
This study looks at how high-risk individuals in Taiwan, like smokers or those with a family history of lung cancer, are getting screened for lung cancer using low-dose CT scans to see how effective these screenings are.
-
Wintergreen oil inhalation for shortness of breath in pneumonia patients
Hospitals will test whether inhaling wintergreen essential oil helps relieve dyspnea in adults with pneumonia.
-
Difference in finger, earlobe, and forehead oxygen levels to predict outcomes in dyspnea
In adults with breathing trouble, this study tests whether differences in SpO2 readings from different body sites can predict who might have worse outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.